Cargando…
mTOR-dependent autophagy contributes to end-organ resistance and serves as target for treatment in autoimmune disease
Autor principal: | Perl, Andras |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6197622/ https://www.ncbi.nlm.nih.gov/pubmed/30262258 http://dx.doi.org/10.1016/j.ebiom.2018.09.033 |
Ejemplares similares
-
Therapeutic mTOR blockade in systemic autoimmunity: Implications for antiviral immunity and extension of lifespan
por: Geier, Christian, et al.
Publicado: (2021) -
mTOR and its link to the picture of Dorian Gray - re-activation of mTOR promotes aging
por: Węsierska-Gądek, Józefa
Publicado: (2010) -
mTOR, autophagy, and reprogramming
por: Tang, Bor Luen
Publicado: (2014) -
Decision-making by p53 and mTOR
por: Maki, Carl G.
Publicado: (2010) -
FUS contributes to mTOR-dependent inhibition of translation
por: Sévigny, Myriam, et al.
Publicado: (2021)